Sensitive ASX Announcement

FDA grants Orphan Drug Designation for NNZ-2591 in Angelman

Published: 11/10/19, 01:21pm (AEST)2 pages
Neuren Pharmaceuticals Limited
NEU:ASXHealthcare

Recent NEU Announcements

Price Sensitive only